-Joel Adamson Researcher Activity Profile

Research Author Detailed Information 

Joel Adamson Publication Rate By Year

Joel Adamson has published 1 paper(s) in 2006, 11 paper(s) in 2007, 8 paper(s) in 2008, for a total of 20 research publications in total.

Joel J Adamson Author Information

LAST NAME: adamson

FIRST NAME: Joel

INITIALS: j

AFFILIATION:

Papers

Joel Adamson's Publication Record

1. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Year Published: 2007
Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. twilens@partners.org
2. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Year Published: 2006
Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
3. Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD. Year Published: 2007
Laboratory of Neurogenetics, National Institute of Aging, NIH, Bethesda, MD, USA. momeni@mail.nih.gov <momeni@mail.nih.gov>
4. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. Year Published: 2007
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
5. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Year Published: 2007
Division of Behavioral Neurology, Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
6. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
7. Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder. Year Published: 2007
Pediatric Psychopharmacology Unit, Massachusetts General Hospital, and Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02114, USA. twilens@partners.org
8. Clinicopathologic correlation in PGRN mutations. Year Published: 2007
Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
9. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA. rademakers.rosa@mayo.edu
10. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Year Published: 2007
Departments of Psychiatry and Neuroscience & Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
11. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Year Published: 2007
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA. rademakers.rosa@mayo.edu
12. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Year Published: 2007
Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY 13210, USA. faraones@upstate.edu
13. New Genes, New Dilemmas: FTLD Genetics and Its Implications for Families. Year Published: 2008
Sergievsky Center and Taub Institute, Columbia University, New York. jg2673@columbia.edu.
14. Automated collection of double red blood cell units with a variable-volume separation chamber. Year Published: 2008
Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
15. New genes, new dilemmas: FTLD genetics and its implications for families. Year Published: 2008
Sergievsky Center and Taub Institute, Columbia University, New York, NY 10036, USA. jg2673@columbia.edu
16. Automated collection of double red blood cell units with a variable-volume separation chamber. Year Published: 2008
Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA. james.p.aubuchon@hitchcock.org
17. Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression. Year Published: 2008
Molecular Pathology Laboratory, School of Cancer Studies, Faculty of Medicine, the University of Liverpool, Liverpool, L69 3GA, UK.
18. Meaningful differences in maternal smoking behaviour during pregnancy: implications for infant behavioural vulnerability. Year Published: 2008
Department of Health Sciences, University of York, Seebohm Rowntree Building, Area 3, Heslington, York YO10 5DD, UK. kp6@york.ac.uk
19. Improving the effectiveness of interventions in palliative care: the potential role of qualitative research in enhancing evidence from randomized controlled trials. Year Published: 2008
Department of Health Sciences, The University of York, York.
20. New genes, new dilemmas: FTLD genetics and its implications for families. Year Published: 2008
Sergievsky Center and Taub Institute, Columbia University, New York, NY 10036, USA. jg2673@columbia.edu